TUESDAY, Feb. 4, 2014 (HealthDay News) -- It's well known that
having type 2 diabetes can increase a person's chances of impaired
memory and thinking. But a new study suggests that intensive
treatment of blood pressure and cholesterol levels in people with
diabetes won't help lower that risk.
"The finding that intensive blood pressure lowering did not impact [mental] decline in patients with diabetes seems to be consistent with recent trials in patients with diabetes that [showed that] lower is not necessarily better," said one expert, Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y. Marzo was not involved in the new research.
The study, published online Feb. 3 in the journal
JAMA Internal Medicine, tracked outcomes for nearly 3,000
people with type 2 diabetes who had no deficits in memory or
thinking and showed no other signs of dementia at the beginning of
The patients had taken part in the Action to Control
Cardiovascular Risk in Diabetes (ACCORD) trial. Some of them got
"intensive" therapy to lower their systolic blood pressure -- the
top number in a reading -- to below 120 millimeters of mercury
(mm/Hg), while a comparison group got "standard" blood pressure
therapy with a goal of lower than 140 mm/Hg.
Other patients in the trial received intensive therapy to battle
high cholesterol, which meant adding a fibrate drug to a statin
medication to try to bring blood cholesterol levels to below 100
milligrams per deciliter. A comparison group got standard
cholesterol treatment -- the statin alone -- plus a placebo.
After more than three years of follow-up, the researchers, led
by Dr. Jeff Williamson of the Wake Forest School of Medicine, said
they observed no differences in the mental function of people who
got intensive therapies versus those who got the standard
The researchers also looked at the total brain volume of some
people in each group, because lessening brain volume has been
linked to mental decline.
People in the intensive blood-pressure-lowering group seemed to
have less reduction in brain volume than those who got standard
blood pressure care, Williamson's team found. Adding the fibrate
drug to cholesterol care appeared to have no impact on brain
The study authors said there has been a lot of attention given
to the possibility that better control of blood pressure and
cholesterol might help people with diabetes avoid mental
But although these types of treatments might be helpful for
people with heart disease or stroke, the researchers said, the
current study showed no overall reduction in the rate of mental
decline linked to type 2 diabetes after intensive blood pressure
and cholesterol control.
Other experts in diabetes and its relationship to heart health
said more research might be necessary, however.
"Diabetes, along with its associated hypertension and cholesterol disorders, can significantly affect the small blood vessels in the brain," said Dr. Valentin Fuster, director of the division of cardiology at Mount Sinai Hospital in New York City. "However, diabetes, hypertension and cholesterol disorders take years to cause effects on the brain."
That means a study that followed patients for only about three
years might simply be too short, said Fuster, who is also upcoming
editor-in-chief of the
Journal of the American College of Cardiology.
"Furthermore, the damage exerted in the brain by diabetes and its associated hypertension and cholesterol disorders may already be irreversible," he said. "If so, one could not expect significant changes with treatment."
Dr. Spyros Mezitis is an endocrinologist and diabetes specialist
at Lenox Hill Hospital in New York City. He agreed with Fuster that
the Wake Forest findings "may come as a surprise to many physicians
who know there is decreased risk for stroke and heart attacks in
diabetic patients with intensively controlled hypertension and high
"More studies need to be performed in this area of diabetic research," Mezitis said.
For his part, Marzo said the new study "supports present
recommendations that physicians have their diabetic patients live a
healthy lifestyle with diet and exercise, control blood pressure to
a goal of 140/90 mmHg and treat cholesterol with a statin."
There's more on type 2 diabetes and heart disease at the
American Diabetes Association.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.